High-dose Versus Low-dose Cyclophosphamide in Combination with G-CSF for Peripheral Blood Progenitor Cell Mobilization
Jin Seok Ahn, Seonyang Park, Seock-Ah Im, Sung-Soo Yoon, Jong-Seok Lee, Byoung Kook Kim, Soo-Mee Bang, Eun Kyung Cho, Jae Hoon Lee, Chul Won Jung, Hugh Chul Kim, Chu Myung Seong, Moon Hee Lee, Chul Soo Kim, Keun Seok Lee, Jung Ae Lee, Myung-Ju Ahn
Korean J Intern Med. 2005;20(3):224-231. Published online September 30, 2005
BackgroundTo compare the mobilizing effects and toxicities of two different doses of cyclophosphamide (CY) plus lenograstim (glycosylated G-CSF), we performed a prospective randomized study by enrolling patients suffering with either high-risk Non-Hodgkin's lymphoma (NHL) or b..
|
|
Sweet`s syndrome during the treatment of acute promyelocytic leukemia with all - trans retinoic acid
Chi Jun Park, Young Deok Bae, Ji Yong Choi, Pil Seog Heo, Keun Seok Lee, Young Suk Park, Jung Ae Lee
Korean J Intern Med. 2001;16(3):218-221. Published online September 1, 2001
|
|
Prognostic Factors of Patients With Thymoma
Won Sup Lee, Dae Seog Heo, Yung Jue Bang, Keun Seok Lee, Jin Seok Ahn, Chul Won Jung, Sung Koo Han, Sook Whan Sung, Joo Hyun Kim, Young Soo Shim, Chan Il Park, Noe Kyeong Kim
Korean J Intern Med. 1996;11(1):40-49. Published online January 1, 1996
|
|
|